​​Deadline 10 June 2026 (late breaking 1 Sept 2026)​

​

The organisers of the Mt Hood 2026 Conference invite the submission of abstracts presenting original research and methodological advances in health economic modelling. Consistent with the tradition of the Mt Hood Conferences, contributions should focus on improving the transparency, validity, and application of models used to inform healthcare decision-making.

While the Mt Hood conference series has historically focused on the economics of diabetes, submissions are not restricted to a specific disease area. Abstracts addressing other conditions, including comorbidities such as dementia, are welcome. In particular, the conference encourages work that addresses general methodological challenges and innovations in simulation modelling, regardless of clinical context.

​

Abstracts must be submitted electronically via the conference system by the stated deadline. Submissions should be in English and must not exceed 300 words (excluding title and authors). Abstracts should be structured with background, methods, results, and conclusions, and clearly describe the objectives, approach, and key findings.

​

All abstracts will be peer reviewed by the scientific committee and assessed on relevance, methodological quality, clarity, and contribution to best practice. Accepted abstracts will be selected for oral or poster presentation. At least one author of each accepted abstract must register for the conference.

​

By submitting an abstract, authors confirm that the work is original, approved by all co-authors, and may be published in conference materials.

​

The presenters of research are required to disclose financial support. Abstract review will NOT be based on this information.

​​

Abstract formatting guidelines:

​​

• Full name and details of affiliations of all authors.

• Details of presenter including contact email

• The research abstracts, EXCLUDING title and author information, should be no longer than 300 words.

• The use of tables, graphs and figures in your research abstract submission are not allowed.

• Generic names should be used for technologies (drugs, devices), not trade names.

• Research that has been published at any national or international meeting prior to this Conference is discouraged.

​​

Organized sessions in which several presentations are combined with a theme will be considered. It would be useful to contact the Mt Hood Challenge steering committee with draft proposals before the deadline so that they can assist with co-ordinating these sessions.

​

The deadline for abstracts is 15 June 2026, but we will try to accommodate late breaking abstracts up until 1 September if there are presentation slots availiable.